Acurx Pharmaceuticals Inc (NASDAQ:ACXP) has a beta value of -1.31 and has seen 1.57 million shares traded in the last trading session. The company, currently valued at $14.76M, closed the last trade at $0.63 per share which meant it gained $0.03 on the day or 4.32% during that session. The ACXP stock price is -428.57% off its 52-week high price of $3.33 and 52.38% above the 52-week low of $0.30. If we look at the company’s 10-day average daily trading volume, we find that it stood at 36.52 million shares traded. The 3-month trading volume is 5.92 million shares.
Acurx Pharmaceuticals Inc (NASDAQ:ACXP) trade information
Sporting 4.32% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ACXP stock price touched $0.63 or saw a rise of 40.0%. Year-to-date, Acurx Pharmaceuticals Inc shares have moved -71.82%, while the 5-day performance has seen it change 104.66%. Over the past 30 days, the shares of Acurx Pharmaceuticals Inc (NASDAQ:ACXP) have changed 57.84%. Short interest in the company has seen 0.3 million shares shorted with days to cover at 1.47.
Acurx Pharmaceuticals Inc (ACXP) estimates and forecasts
The company’s shares have lost -12.72% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -7.84% over the past 5 years. Earnings growth for 2025 is a modest 42.53% while over the next 5 years, the company’s earnings are expected to increase by 15.59%.
ACXP Dividends
Acurx Pharmaceuticals Inc is expected to release its next earnings report on 2025-May-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Acurx Pharmaceuticals Inc (NASDAQ:ACXP)’s Major holders
Insiders own 10.95% of the company shares, while shares held by institutions stand at 17.99% with a share float percentage of 20.20%. Investors are also buoyed by the number of investors in a company, with Acurx Pharmaceuticals Inc having a total of 27.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 0.49 million shares worth more than $1.11 million. As of 2024-06-30, VANGUARD GROUP INC held 3.1071% of shares outstanding.
The other major institutional holder is PROSPECT FINANCIAL SERVICES LLC, with the holding of over 0.28 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.63 million and represent 1.7574% of shares outstanding.
